Promising Biomarkers of Environmental Enteric Dysfunction: A Prospective Cohort study in

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Iqbal, Najeeha Talat ^a   Sadiq, Kamran ^a   Syed, Sana ^a,b   Akhund, Tauseefullah ^a   Umrani, Fayyaz ^a   Ahmed, Sheraz ^a   Yakoob, Mohammad Yawar ^a   Rahman, Najeeb ^a   Qureshi, Shahida ^a   Xin, Wenjun ^c   Ma, Jennie Z ^c   Hughes, Molly ^b   Ali, Syed Asad ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCAGON LIKE PEPTIDE 2; IGF1 PROTEIN, HUMAN; PEROXIDASE; SOMATOMEDIN C;

ADVERSE EVENT; BLOOD; COHORT ANALYSIS; ENTEROPATHY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; FEMALE; HUMAN; INFANT; INTESTINE CELL; LEUKOCYTE ACTIVATION; MALE; METABOLISM; NEWBORN; PAKISTAN; PHYSIOLOGY; PROSPECTIVE STUDY; STATISTICAL MODEL; SYNDROME;

BIOMARKERS; COHORT STUDIES; ENTEROCYTES; ENVIRONMENTAL EXPOSURE; FEMALE; GLUCAGON-LIKE PEPTIDE 2; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL DISEASES; MALE; MODELS, STATISTICAL; NEUTROPHIL ACTIVATION; PAKISTAN; PEROXIDASE; PROSPECTIVE STUDIES; SYNDROME;

EID: 85042129534     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-21319-8     Document Type: Article

References (30)

1. Lin, A. et al. Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am. J Trop. Med Hyg. 89(1), 130 (2013).
2. Campbell, D. I. et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr. Res. 54(3), 306 (2003).
3. Kelly, P. et al. Endomicroscopic and Transcriptomic Analysis of Impaired Barrier Function and Malabsorption in Environmental Enteropathy. PLoS. Negl. Trop. Dis. 10(4), e0004600 (2016).
4. Levine, M. M. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC. Biol. 8, 129 (2010).
5. Owino V. et al. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global Child Health. Pediatrics 138(6) (2016).
6. Piwoz, E., Sundberg, S. & Rooke, J. Promoting healthy growth: what are the priorities for research and action? Adv. Nutr 3(2), 234 (2012).
7. Ahmed, S. et al. Challenges in Implementation of the ANISA Protocol at the Matiari Site, Pakistan. Pediatr. Infect. Dis. J 35(5 Suppl 1), S65-S69 (2016).
8. Kosek, M. et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am. J Trop. Med Hyg. 88(2), 390 (2013).
9. Naylor, C. et al. Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh. EBioMedicine. 2(11), 1759 (2015).
10. Wong, S. C. et al. The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation. J. Pediatr. Gastroenterol. Nutr. 43(2), 144 (2006).
11. Denson, L. A. et al. Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am. J. Physiol Gastrointest. Liver Physiol 284(4), G646-G654 (2003).
12. Rao A. et al. Mathematical modelling to restore circulating IGF-1 concentrations in children with Crohn's disease-induced growth failure: a pharmacokinetic study. BMJ Open. 3(5) (2013).
13. Boushey, R. P., Yusta, B. & Drucker, D. J. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacininduced murine enteritis. Am. J. Physiol 277(5 Pt 1), E937-E947 (1999).
14. Jeppesen, P. B. et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120(4), 806 (2001).
15. Caddy, G. R. et al. Plasma concentrations of glucagon-like peptide-2 in adult patients with treated and untreated coeliac disease. Eur. J. Gastroenterol. Hepatol. 18(2), 195 (2006).
16. Saiki, T. Myeloperoxidase concentrations in the stool as a new parameter of inflammatory bowel disease. Kurume Med J 45(1), 69 (1998).
17. Kosek, M. N. Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort Study. EBioMedicine 18, 109 (2017).
18. Dieckgraefe, B. K. et al. Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha upregulation, processing, and antiapoptotic activity. J. Investig. Med. 50(6), 421 (2002).
19. Sekikawa, A. et al. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer. Gut 54(10), 1437 (2005).
20. Fukuhara, H. et al. In vivo evidence for the role of RegI in gastric regeneration: transgenic overexpression of RegI accelerates the healing of experimental gastric ulcers. Lab Invest 90(4), 556 (2010).
21. Kawanami, C. et al. Regenerating gene expression in normal gastric mucosa and indomethacin-induced mucosal lesions of the rat. J. Gastroenterol 32(1), 12 (1997).
22. Imaoka, H. et al. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice. Am. J. Physiol Gastrointest. Liver Physiol 299(2), G311-G319 (2010).
23. Planas, R. et al. Regenerating gene Ialpha is a biomarker for diagnosis and monitoring of celiac disease: a preliminary study. Transl. Res 158(3), 140 (2011).
24. Marafini, I. et al. Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies. Aliment. Pharmacol. Ther 40(8), 974 (2014).
25. Peterson, K. M. et al. REG1B as a predictor of childhood stunting in Bangladesh and Peru. Am. J Clin. Nutr 97(5), 1129 (2013).
26. Prendergast, A. J. et al. Stunting is characterized by chronic inflammation in Zimbabwean infants. PLoS One 9(2), e86928 (2014).
27. Jones, K. D. et al. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC. Med 12, 133 (2014).
28. Bartz, S. et al. evere acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin. Endocrinol. Metab 99(6), 2128 (2014).
29. Arndt M. B. et al. Fecal Markers of Environmental Enteropathy and Subsequent Growth in Bangladeshi Children. Am. J. Trop. Med. Hyg. (2016).
30. Prendergast, A. J. & Kelly, P. Interactions between intestinal pathogens, enteropathy and malnutrition in developing countries. Curr. Opin. Infect. Dis 29(3), 229 (2016).